IML provides a publication-ready framework for assessing health systems, exchange architectures, identity layers and real-world deployment capacity. It helps institutions move from fragmented digital initiatives to governed interoperability at scale.
IML can be aligned with ID4D by treating digital identity as an enabling public infrastructure layer for inclusive access, trusted service delivery, interoperability and accountable governance.
Health interoperability maturity directly affects clinical evaluation, trial design, long-term follow-up and regulatory decision-making.
A mature interoperability and identity layer can make it possible to assemble a safeguarded, person-linked longitudinal view of clinically relevant information across prescriptions, dispensing events, laboratory results, care episodes, prior conditions and follow-up signals.
The larger point is that health systems are still at an early stage in their use of new technologies. What is visible today is important, but it likely represents only the first layer of what interoperable, identity-aware and clinically usable digital infrastructures could support over time.
The IML methodology combines six assessment dimensions, a maturity score, country benchmarking and a trust-oriented view of digital identity.
This rebuilt version restores the detailed explanatory panel for each country, with expandable sections for strengths, points to watch, examples and sources.
Hover a marker to preview a country. Click a marker or use the dropdown to open the full explanatory panel below.
Interoperability maturity does not depend only on standards or digital infrastructure. It depends on how identity, governance, trust, medicines information, deployment and correction capacity reinforce one another in practice.
For publication matters, country notes, methodological discussion and institutional exchanges, please use the contact address below.
Email: iml.health@pm.me
